GLAXOSMITHKLINE S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.08 EGP | +3.32% |
|
-3.84% | -12.57% |
Quotes 5-day view
End-of-day quote Egyptian Exchange| 2024-04-28 | 2024-04-29 | 2024-04-30 | 2024-05-01 | 2024-05-02 | |
|---|---|---|---|---|---|
| Last | 30.89 £ | 30.78 £ | 30.08 £ | 30.08 £ | 31.08 £ |
| Volume | 10 376 | 26 723 | 21 406 | 9 013 | 13 224 |
| Change | +∞% | -0.36% | -2.27% | 0.00% | +3.32% |
| Opening | 32.32 | 30.89 | 30.78 | 30.08 | 30.08 |
| High | 32.33 | 31.88 | 31.69 | 30.90 | 31.50 |
| Low | 30.51 | 29.19 | 30.00 | 29.96 | 30.00 |
Performance
| 1 day | +3.32% | ||
| 1 week | -3.84% | ||
| Current month | +3.32% | ||
| 1 month | +3.50% | ||
| 3 months | -13.23% | ||
| 6 months | -2.33% | ||
| Current year | -12.57% | ||
| 1 year | -4.19% | ||
| 3 years | +18.26% | ||
| 10 years | +124.89% |
Volumes
marketsDaily volume
13 224
Avg. Volume 20 sessions
33 463
Avg. Volume 20 sessions EGP
1 040 030.04
Avg. Volume 20 sessions USD
21 712.71
Record volume 1
763 890
Record volume 2
619 100
Record volume 3
594 277
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (EGP)
2 592 985 151
Capitalization (USD)
54 133 751
Net sales (EGP)
2 240 219 838
Net sales (USD)
46 769 070
Free-Float
2.91 %
Free-Float capitalization (EGP)
75 580 334
Free-Float capitalization (USD)
1 577 891
Average Daily Capital Traded
0.04%
Highs and lows
1 week
29.19
32.33
1 month
29.1936.00
Current year
28.2047.50
1 year
26.2647.50
3 years
16.6647.50
5 years
5.7747.50
10 years
0.0047.50
Indicators
Moving average 5 days
30.58
Moving average 20 days
31.23
Moving average 50 days
34.29
Moving average 100 days
35.64
Price spread / (MMA5)
-1.61%
Price spread / (MMA20)
+0.48%
Price spread / (MMA50)
+10.33%
Price spread / (MMA100)
+14.67%
STIM
RSI 9 days
46.98
RSI 14 days
45.21
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.32% | -3.84% | -12.57% | -4.19% | 54.13M | ||
| -2.58% | -4.06% | +21.85% | +51.46% | 546B | ||
| -0.43% | +2.14% | -4.77% | -8.35% | 359B | ||
| -0.58% | -2.80% | +16.97% | +7.87% | 323B | ||
| +1.85% | +2.61% | +5.69% | +9.74% | 290B | ||
| -0.87% | +0.52% | +13.68% | +1.40% | 234B | ||
| -1.01% | -1.71% | +3.65% | -4.91% | 198B | ||
| +1.49% | -1.67% | -11.12% | -22.70% | 194B | ||
| +11.82% | +15.30% | +8.08% | +34.24% | 167B | ||
| +0.40% | +9.49% | -3.40% | -27.67% | 157B | ||
| -0.65% | +0.08% | +1.72% | -6.75% | 123B | ||
| +0.66% | -1.92% | -14.27% | -33.99% | 89.17B | ||
| +0.29% | +4.87% | +19.54% | +17.88% | 88.72B | ||
| -0.84% | -0.98% | -20.03% | -17.50% | 80.78B | ||
| +3.13% | +9.82% | +42.10% | +17.39% | 69B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +1.00% | +2.26% | +4.47% | +0.93% | ||
| Weighted average by Cap. | +0.29% | +0.93% | +7.50% | +8.32% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -12.57% | ||
| 2023 | -6.84% | ||
| 2022 | +23.58% | ||
| 2021 | +82.08% | ||
| 2020 | -14.17% | ||
| 2018 | -100.00% | ||
| 2017 | +81.72% | ||
| 2016 | -11.39% | ||
| 2015 | -10.00% | ||
| 2014 | -20.11% | ||
| 2013 | +53.22% | ||
| 2012 | +0.42% | ||
| 2011 | -39.24% | ||
| 2010 | +18.18% | ||
| 2009 | +24.72% | ||
| 2008 | -47.68% | ||
| 2007 | +0.89% | ||
| 2006 | +104.33% | ||
| 2005 | +6.65% |
- Stock Market
- Equities
- BIOC Stock
- Quotes GlaxoSmithKline S.A.E
